The Current Treatment Paradigm for Pancreatic Ductal Adenocarcinoma and Barriers to Therapeutic Efficacy
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Current Treatment Paradigm for Pancreatic Ductal Adenocarcinoma and Barriers to Therapeutic Efficacy
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 11, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-07-15
DOI
10.3389/fonc.2021.688377
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A MET Targeting Antibody-Drug Conjugate Overcomes Gemcitabine Resistance in Pancreatic Cancer
- (2021) Alex Cazes et al. CLINICAL CANCER RESEARCH
- Trials and tribulations of pancreatic cancer immunotherapy
- (2021) Daniel R. Principe et al. CANCER LETTERS
- Cancer statistics, 2020
- (2020) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Randomized, Multicenter, Phase II Trial of Gemcitabine and Cisplatin With or Without Veliparib in Patients With Pancreas Adenocarcinoma and a Germline BRCA/PALB2 Mutation
- (2020) Eileen M. O’Reilly et al. JOURNAL OF CLINICAL ONCOLOGY
- Preoperative Chemoradiotherapy Versus Immediate Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Results of the Dutch Randomized Phase III PREOPANC Trial
- (2020) Eva Versteijne et al. JOURNAL OF CLINICAL ONCOLOGY
- Neoadjuvant chemotherapy for primary resectable pancreatic cancer: a systematic review and meta-analysis
- (2020) Mao Ye et al. HPB
- Updated risk factors to inform early pancreatic cancer screening and identify high risk patients
- (2020) Daniel R. Principe et al. CANCER LETTERS
- Small Molecule KRAS Inhibitors: The Future for Targeted Pancreatic Cancer Therapy?
- (2020) Josef Gillson et al. Cancers
- Detection of Chemotherapy-Resistant Pancreatic Cancer Using a Glycan Biomarker, sTRA
- (2020) Chong-Feng Gao et al. CLINICAL CANCER RESEARCH
- Frequency and prognostic value of mutations associated with the homologous recombination DNA repair pathway in a large pan cancer cohort
- (2020) Daniel R. Principe et al. Scientific Reports
- A transcriptomic signature to predict adjuvant gemcitabine sensitivity in pancreatic adenocarcinoma
- (2020) R. Nicolle et al. ANNALS OF ONCOLOGY
- Cytosolic 5′-nucleotidase 1A is overexpressed in pancreatic cancer and mediates gemcitabine resistance by reducing intracellular gemcitabine metabolites
- (2019) Melanie S. Patzak et al. EBioMedicine
- Liposomal irinotecan and 5-fluorouracil/leucovorin in older patients with metastatic pancreatic cancer – A subgroup analysis of the pivotal NAPOLI-1 trial
- (2019) Teresa Macarulla et al. Journal of Geriatric Oncology
- A Phase II Randomized Trial of Panitumumab, Erlotinib, and Gemcitabine Versus Erlotinib and Gemcitabine in Patients with Untreated, Metastatic Pancreatic Adenocarcinoma: North Central Cancer Treatment Group Trial N064B (Alliance)
- (2019) Thorvardur R. Halfdanarson et al. ONCOLOGIST
- Therapeutic efficacy of a novel βIII/βIV-tubulin inhibitor (VERU-111) in pancreatic cancer
- (2019) Vivek K. Kashyap et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- NAPOLI-1 phase 3 study of liposomal irinotecan in metastatic pancreatic cancer: Final overall survival analysis and characteristics of long-term survivors
- (2019) Andrea Wang-Gillam et al. EUROPEAN JOURNAL OF CANCER
- Randomized trial of oral versus enteral feeding for patients with postoperative pancreatic fistula after pancreatoduodenectomy
- (2019) J.‐M. Wu et al. BRITISH JOURNAL OF SURGERY
- Neoadjuvant Chemotherapy with Gemcitabine Plus Nab-Paclitaxel for Borderline Resectable Pancreatic Cancer Potentially Improves Survival and Facilitates Surgery
- (2019) Yoshihiro Miyasaka et al. ANNALS OF SURGICAL ONCOLOGY
- Laparoscopic Versus Open Pancreaticoduodenectomy
- (2019) Felix Nickel et al. ANNALS OF SURGERY
- Neoadjuvant FOLFIRINOX in patients with borderline resectable pancreatic cancer: a systematic review and patient-level meta-analysis
- (2019) Quisette P Janssen et al. JNCI-Journal of the National Cancer Institute
- Completion of Adjuvant Chemotherapy After Upfront Surgical Resection for Pancreatic Cancer Is Uncommon Yet Associated With Improved Survival
- (2019) Ariella M. Altman et al. ANNALS OF SURGICAL ONCOLOGY
- Total compared with partial pancreatectomy for pancreatic adenocarcinoma: assessment of resection margin, readmission rate, and survival from the U.S. National Cancer Database
- (2019) M. J. Passeri et al. Current Oncology
- Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer
- (2019) Talia Golan et al. NEW ENGLAND JOURNAL OF MEDICINE
- A meta-analysis of randomized controlled trials comparing laparoscopic vs open pancreaticoduodenectomy
- (2019) Fabio Ausania et al. HPB
- Systematic review of functional outcome and quality of life after total pancreatectomy
- (2019) L. Scholten et al. BRITISH JOURNAL OF SURGERY
- Outcome and long-term quality of life after total pancreatectomy (PANORAMA): a nationwide cohort study
- (2019) Lianne Scholten et al. SURGERY
- Completion of adjuvant therapy in patients with resected pancreatic cancer
- (2019) Danielle K. DePeralta et al. HPB
- Efficacy of Pembrolizumab in Patients With Noncolorectal High Microsatellite Instability/Mismatch Repair–Deficient Cancer: Results From the Phase II KEYNOTE-158 Study
- (2019) Aurelien Marabelle et al. JOURNAL OF CLINICAL ONCOLOGY
- From state-of-the-art treatments to novel therapies for advanced-stage pancreatic cancer
- (2019) Christopher Nevala-Plagemann et al. Nature Reviews Clinical Oncology
- A prospective single-center protocol for using near-infrared fluorescence imaging with indocyanine green during staging laparoscopy to detect small metastasis from pancreatic cancer
- (2019) Sachiyo Shirakawa et al. BMC Surgery
- The Impact of Socioeconomic Deprivation on Clinical Outcomes for Pancreatic Adenocarcinoma at a High-volume Cancer Center
- (2019) Benjamin D. Powers et al. ANNALS OF SURGERY
- Oncological Benefits of Neoadjuvant Chemoradiation With Gemcitabine Versus Upfront Surgery in Patients With Borderline Resectable Pancreatic Cancer
- (2018) Jin-Young Jang et al. ANNALS OF SURGERY
- Survival in Locally Advanced Pancreatic Cancer After Neoadjuvant Therapy and Surgical Resection
- (2018) Georgios Gemenetzis et al. ANNALS OF SURGERY
- Health Disparities Impact Expected Treatment of Pancreatic Ductal Adenocarcinoma Nationally
- (2018) Waseem Lutfi et al. ANNALS OF SURGICAL ONCOLOGY
- Meta-analysis of an artery-first approach versus standard pancreatoduodenectomy on perioperative outcomes and survival
- (2018) N. Ironside et al. BRITISH JOURNAL OF SURGERY
- Targeting KRAS Mutant Cancers with a Covalent G12C-Specific Inhibitor
- (2018) Matthew R. Janes et al. CELL
- Evaluating Mismatch Repair Deficiency in Pancreatic Adenocarcinoma: Challenges and Recommendations
- (2018) Zishuo I. Hu et al. CLINICAL CANCER RESEARCH
- The Additional Value of Laparoscopic Ultrasound to Staging Laparoscopy in Patients with Suspected Pancreatic Head Cancer
- (2018) Gijs A. Looijen et al. JOURNAL OF GASTROINTESTINAL SURGERY
- Impact of age on survival of patients with pancreatic cancer after surgery: Analysis of SEER data
- (2018) Xiaogang Li et al. PANCREATOLOGY
- Preoperative biliary drainage in resectable pancreatic cancer: a systematic review and network meta-analysis
- (2018) Peter J. Lee et al. HPB
- Natural compound Oblongifolin C confers gemcitabine resistance in pancreatic cancer by downregulating Src/MAPK/ERK pathways
- (2018) Yang Li et al. Cell Death & Disease
- Disparities in cancer outcomes across age, sex, and race/ethnicity among patients with pancreatic cancer
- (2018) Ryan Nipp et al. Cancer Medicine
- Cancer-associated cachexia
- (2018) Vickie E. Baracos et al. Nature Reviews Disease Primers
- Total Neoadjuvant Therapy With FOLFIRINOX Followed by Individualized Chemoradiotherapy for Borderline Resectable Pancreatic Adenocarcinoma
- (2018) Janet E. Murphy et al. JAMA Oncology
- Minimally Invasive Versus Open Distal Pancreatectomy (LEOPARD)
- (2018) Thijs de Rooij et al. ANNALS OF SURGERY
- Comparison of Perioperative Outcomes Between Laparoscopic and Open Approach for Pancreatoduodenectomy
- (2018) Ignasi Poves et al. ANNALS OF SURGERY
- Incidence and risk factors for abdominal occult metastatic disease in patients with pancreatic adenocarcinoma
- (2018) Georgios Gemenetzis et al. JOURNAL OF SURGICAL ONCOLOGY
- TGFβ Blockade Augments PD-1 Inhibition to Promote T-Cell Mediated Regression of Pancreatic Cancer
- (2018) Daniel R Principe et al. MOLECULAR CANCER THERAPEUTICS
- Optimizing the outcomes of pancreatic cancer surgery
- (2018) Oliver Strobel et al. Nature Reviews Clinical Oncology
- FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer
- (2018) Thierry Conroy et al. NEW ENGLAND JOURNAL OF MEDICINE
- The role of GLI-SOX2 signaling axis for gemcitabine resistance in pancreatic cancer
- (2018) Yanfei Jia et al. ONCOGENE
- Staging laparoscopy with ultrasound and near-infrared fluorescence imaging to detect occult metastases of pancreatic and periampullary cancer
- (2018) H. J. M. Handgraaf et al. PLoS One
- Resection of pancreatic cancer in Europe and USA: an international large-scale study highlighting large variations
- (2017) Lei Huang et al. GUT
- Taxol®: The First Microtubule Stabilizing Agent
- (2017) Chia-Ping Yang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- A phase Ib/II pilot trial with nab-paclitaxel plus gemcitabine plus cisplatin in patients (pts) with stage IV pancreatic cancer.
- (2017) Gayle S. Jameson et al. JOURNAL OF CLINICAL ONCOLOGY
- Effect of ribonucleotide reductase M1 expression on overall survival in patients with pancreatic cancer receiving gemcitabine chemotherapy: A literature-based meta-analysis
- (2017) Q. L. Han et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- 5-FU resistant EMT-like pancreatic cancer cells are hypersensitive to photochemical internalization of the novel endoglin-targeting immunotoxin CD105-saporin
- (2017) Kaja Lund et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Diagnostic Laparoscopy Prior to Neoadjuvant Therapy in Pancreatic Cancer Is High Yield: an Analysis of Outcomes and Costs
- (2017) June S. Peng et al. JOURNAL OF GASTROINTESTINAL SURGERY
- Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial
- (2017) John P Neoptolemos et al. LANCET
- Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer
- (2017) Sushrut Kamerkar et al. NATURE
- Minimally invasive versus open distal pancreatectomy for ductal adenocarcinoma (DIPLOMA): A European propensity score matched study
- (2017) Jony van Hilst et al. PANCREATOLOGY
- Hippo pathway mediates resistance to cytotoxic drugs
- (2017) Taranjit S. Gujral et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine
- (2017) Leore T. Geller et al. SCIENCE
- Preoperative biliary stenting versus operation first in jaundiced patients due to malignant lesions in the pancreatic head: A meta-analysis of current literature
- (2017) Florian Scheufele et al. SURGERY
- A clinically applicable muscular index predicts long-term survival in resectable pancreatic cancer
- (2017) Daniel Delitto et al. SURGERY
- “Take the Volume Pledge” may result in disparity in access to care
- (2017) Barbara A. Blanco et al. SURGERY
- Minimally invasive surgical approaches offer earlier time to adjuvant chemotherapy but not improved survival in resected pancreatic cancer
- (2017) Katelin A. Mirkin et al. SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES
- Safety and Antitumor Activity of the Multitargeted Pan-TRK, ROS1, and ALK Inhibitor Entrectinib: Combined Results from Two Phase I Trials (ALKA-372-001 and STARTRK-1)
- (2017) Alexander Drilon et al. Cancer Discovery
- Nanoparticle albumin-bound paclitaxel as neoadjuvant chemotherapy of breast cancer: a systematic review and meta-analysis
- (2017) Yu Zong et al. Oncotarget
- KRAS: The Critical Driver and Therapeutic Target for Pancreatic Cancer
- (2017) Andrew M. Waters et al. Cold Spring Harbor Perspectives in Medicine
- Macropinocytosis of Nab-paclitaxel Drives Macrophage Activation in Pancreatic Cancer
- (2017) Jane Cullis et al. Cancer Immunology Research
- Metastatic Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline Summary
- (2017) Davendra P.S. Sohal et al. Journal of Oncology Practice
- Early Enteral Versus Total Parenteral Nutrition in Patients Undergoing Pancreaticoduodenectomy
- (2016) Julie Perinel et al. ANNALS OF SURGERY
- Hepatocyte growth factor inhibition: a novel therapeutic approach in pancreatic cancer
- (2016) Srinivasa P Pothula et al. BRITISH JOURNAL OF CANCER
- Time to the initiation of adjuvant chemotherapy does not impact survival in patients with resected pancreatic cancer
- (2016) Katelin A. Mirkin et al. CANCER
- TGF Signaling in the Pancreatic Tumor Microenvironment Promotes Fibrosis and Immune Evasion to Facilitate Tumorigenesis
- (2016) D. R. Principe et al. CANCER RESEARCH
- Loss of P53 Function Activates JAK2–STAT3 Signaling to Promote Pancreatic Tumor Growth, Stroma Modification, and Gemcitabine Resistance in Mice and Is Associated With Patient Survival
- (2016) Sonja M. Wörmann et al. GASTROENTEROLOGY
- Learning Curve for Laparoscopic Pancreaticoduodenectomy: a CUSUM Analysis
- (2016) Mingjun Wang et al. JOURNAL OF GASTROINTESTINAL SURGERY
- Pulmonary metastasectomy for suspected pancreaticobiliary cancer
- (2016) Lary A. Robinson et al. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
- FOLFIRINOX for locally advanced pancreatic cancer: a systematic review and patient-level meta-analysis
- (2016) Mustafa Suker et al. LANCET ONCOLOGY
- Distal Pancreatectomy With En Bloc Celiac Axis Resection for Locally Advanced Pancreatic Cancer
- (2016) Haibing Gong et al. MEDICINE
- A wait-and-see strategy with subsequent self-expanding metal stent on demand is superior to prophylactic bypass surgery for unresectable periampullary cancer
- (2016) Caroline Williamsson et al. HPB
- Projections of cancer incidence and cancer-related deaths in Germany by 2020 and 2030
- (2016) Anne S. Quante et al. Cancer Medicine
- Delineating the Role of βIV-Tubulins in Pancreatic Cancer: βIVb-Tubulin Inhibition Sensitizes Pancreatic Cancer Cells to Vinca Alkaloids
- (2016) G. Sharbeen et al. NEOPLASIA
- Pancreatic cancer
- (2016) Jorg Kleeff et al. Nature Reviews Disease Primers
- Minimally Invasive Pancreaticoduodenectomy Does Not Improve Use or Time to Initiation of Adjuvant Chemotherapy for Patients With Pancreatic Adenocarcinoma
- (2015) Daniel P. Nussbaum et al. ANNALS OF SURGICAL ONCOLOGY
- TXNDC17 promotes paclitaxel resistance via inducing autophagy in ovarian cancer
- (2015) Song-Fa Zhang et al. Autophagy
- Non-adherent culture induces paclitaxel resistance in H460 lung cancer cells via ERK-mediated up-regulation of βIVa-tubulin
- (2015) Korakot Atjanasuppat et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Meta-analysis of benefits of portal-superior mesenteric vein resection in pancreatic resection for ductal adenocarcinoma
- (2015) F. Giovinazzo et al. BRITISH JOURNAL OF SURGERY
- Family history as a marker of platinum sensitivity in pancreatic adenocarcinoma
- (2015) David Fogelman et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- miR-16 targets Bcl-2 in paclitaxel-resistant lung cancer cells and overexpression of miR-16 along with miR-17 causes unprecedented sensitivity by simultaneously modulating autophagy and apoptosis
- (2015) Abhisek Chatterjee et al. CELLULAR SIGNALLING
- Albumin-Bound Paclitaxel: A Review in Non-Small Cell Lung Cancer
- (2015) Hannah A. Blair et al. DRUGS
- Pharmacological targeting of the protein synthesis mTOR/4E-BP1 pathway in cancer-associated fibroblasts abrogates pancreatic tumour chemoresistance
- (2015) C. Duluc et al. EMBO Molecular Medicine
- Inhibition of thymidylate synthase by 2′,2′-difluoro-2′-deoxycytidine (Gemcitabine) and its metabolite 2′,2′-difluoro-2′-deoxyuridine
- (2015) Richard J. Honeywell et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Randomized Phase Ib/II Study of Gemcitabine Plus Placebo or Vismodegib, a Hedgehog Pathway Inhibitor, in Patients With Metastatic Pancreatic Cancer
- (2015) Daniel V.T. Catenacci et al. JOURNAL OF CLINICAL ONCOLOGY
- Extended Versus Standard Lymphadenectomy for Pancreatic Head Cancer: Meta-Analysis of Randomized Controlled Trials
- (2015) Bobby V M Dasari et al. JOURNAL OF GASTROINTESTINAL SURGERY
- Early National Experience with Laparoscopic Pancreaticoduodenectomy for Ductal Adenocarcinoma: A Comparison of Laparoscopic Pancreaticoduodenectomy and Open Pancreaticoduodenectomy from the National Cancer Data Base
- (2015) Susan M. Sharpe et al. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS
- Irinotecan, a key chemotherapeutic drug for metastatic colorectal cancer
- (2015) Ken-ichi Fujita WORLD JOURNAL OF GASTROENTEROLOGY
- Intracellular annexin A2 regulates NF-κB signaling by binding to the p50 subunit: implications for gemcitabine resistance in pancreatic cancer
- (2015) H Jung et al. Cell Death & Disease
- Micro RNA 100 sensitizes luminal A breast cancer cells to paclitaxel treatment in part by targeting mTOR
- (2015) Baotong Zhang et al. Oncotarget
- Paracrine SDF-1α signaling mediates the effects of PSCs on GEM chemoresistance through an IL-6 autocrine loop in pancreatic cancer cells
- (2015) Hui Zhang et al. Oncotarget
- Down-regulation of miR-223 reverses epithelial-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells
- (2015) Jia Ma et al. Oncotarget
- Assessment of Quality Outcomes for Robotic Pancreaticoduodenectomy
- (2015) Brian A. Boone et al. JAMA Surgery
- βIII-Tubulin: A novel mediator of chemoresistance and metastases in pancreatic cancer
- (2015) Joshua A. McCarroll et al. Oncotarget
- Roles of the Bcl-2/Bax Ratio, Caspase-8 and 9 in Resistance of Breast Cancer Cells to Paclitaxel
- (2014) Simin Sharifi et al. Asian Pacific Journal of Cancer Prevention
- Phase 2 multi-institutional trial evaluating gemcitabine and stereotactic body radiotherapy for patients with locally advanced unresectable pancreatic adenocarcinoma
- (2014) Joseph M. Herman et al. CANCER
- Gemcitabine resistant pancreatic cancer cell lines acquire an invasive phenotype with collateral hypersensitivity to histone deacetylase inhibitors
- (2014) Betty K Samulitis et al. CANCER BIOLOGY & THERAPY
- Stromal Elements Act to Restrain, Rather Than Support, Pancreatic Ductal Adenocarcinoma
- (2014) Andrew D. Rhim et al. CANCER CELL
- Hippo Signaling Regulates Microprocessor and Links Cell-Density-Dependent miRNA Biogenesis to Cancer
- (2014) Masaki Mori et al. CELL
- Mutant p53 Drives Pancreatic Cancer Metastasis through Cell-Autonomous PDGF Receptor β Signaling
- (2014) Susann Weissmueller et al. CELL
- Nab-paclitaxel: A flattering facelift
- (2014) A. Viúdez et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Gemcitabine Resistance is Associated with Epithelial-Mesenchymal Transition and Induction of HIF-1α in Pancreatic Cancer Cells
- (2014) Rui Wang et al. CURRENT CANCER DRUG TARGETS
- Benefit from synchronous portal-superior mesenteric vein resection during pancreaticoduodenectomy for cancer: A meta-analysis
- (2014) X.Z. Yu et al. EJSO
- How Taxol/paclitaxel kills cancer cells
- (2014) Beth A. Weaver MOLECULAR BIOLOGY OF THE CELL
- Definition of a standard lymphadenectomy in surgery for pancreatic ductal adenocarcinoma: A consensus statement by the International Study Group on Pancreatic Surgery (ISGPS)
- (2014) Johanna A.M.G. Tol et al. SURGERY
- hENT1 expression is predictive of gemcitabine outcome in pancreatic cancer: A systematic review
- (2014) Stina Nordh WORLD JOURNAL OF GASTROENTEROLOGY
- Pancreatic cancer stroma: Understanding biology leads to new therapeutic strategies
- (2014) Agnieszka Anna Rucki WORLD JOURNAL OF GASTROENTEROLOGY
- Meta-analysis of the Efficacies of Extended and Standard Pancreatoduodenectomy for Ductal Adenocarcinoma of the Head of the Pancreas
- (2014) Jingfeng Sun et al. WORLD JOURNAL OF SURGERY
- Adjuvant Chemotherapy With Gemcitabine and Long-term Outcomes Among Patients With Resected Pancreatic Cancer
- (2013) Helmut Oettle et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Trends in Racial Disparities in Pancreatic Cancer Surgery
- (2013) Anand Shah et al. JOURNAL OF GASTROINTESTINAL SURGERY
- ERK1/2 activity contributes to gemcitabine resistance in pancreatic cancer cells
- (2013) Chunning Zheng et al. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
- A Meta-Analysis of Randomized Trials: Immediate Stent Placement vs. Surgical Bypass in the Palliative Management of Malignant Biliary Obstruction
- (2013) Evan S. Glazer et al. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT
- Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
- (2013) Daniel D. Von Hoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Paclitaxel-Induced Apoptosis Is BAK-Dependent, but BAX and BIM-Independent in Breast Tumor
- (2013) Anna V. Miller et al. PLoS One
- Early oral feeding after pancreatoduodenectomy enhances recovery without increasing morbidity
- (2013) Arja Gerritsen et al. HPB
- Hypoxia counteracts taxol-induced apoptosis in MDA-MB-231 breast cancer cells: role of autophagy and JNK activation
- (2013) A Notte et al. Cell Death & Disease
- Clinical and molecular characterization of HER2 amplified-pancreatic cancer
- (2013) Angela Chou et al. Genome Medicine
- Preclinical Absorption, Distribution, Metabolism, and Excretion of an Oral Amide Prodrug of Gemcitabine Designed to Deliver Prolonged Systemic Exposure
- (2013) Enaksha Wickremsinhe et al. Pharmaceutics
- The Impact of Vascular Resection on Early Postoperative Outcomes after Pancreaticoduodenectomy: An Analysis of the American College of Surgeons National Surgical Quality Improvement Program Database
- (2012) Anthony W. Castleberry et al. ANNALS OF SURGICAL ONCOLOGY
- Multicentre phase II trial of trastuzumab and capecitabine in patients with HER2 overexpressing metastatic pancreatic cancer
- (2012) J Harder et al. BRITISH JOURNAL OF CANCER
- ‘Artery-first’ approaches to pancreatoduodenectomy
- (2012) P. Sanjay et al. BRITISH JOURNAL OF SURGERY
- Guidelines for perioperative care for pancreaticoduodenectomy: Enhanced Recovery After Surgery (ERAS®) Society recommendations
- (2012) Kristoffer Lassen et al. CLINICAL NUTRITION
- Irinotecan Resistance is Accompanied by Upregulation of EGFR and Src Signaling in Human Cancer Models
- (2012) Amelie Petitprez et al. CURRENT PHARMACEUTICAL DESIGN
- Hyaluronan impairs vascular function and drug delivery in a mouse model of pancreatic cancer
- (2012) Michael A Jacobetz et al. GUT
- The miR-200 and miR-221/222 microRNA Families: Opposing Effects on Epithelial Identity
- (2012) Erin N. Howe et al. JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA
- Malnutrition and pancreatic surgery: Prevalence and outcomes
- (2012) Marco La Torre et al. JOURNAL OF SURGICAL ONCOLOGY
- Stromal control of cystine metabolism promotes cancer cell survival in chronic lymphocytic leukaemia
- (2012) Wan Zhang et al. NATURE CELL BIOLOGY
- Pancreatectomy Combined with Superior Mesenteric Vein–Portal Vein Resection for Pancreatic Cancer: A Meta-analysis
- (2012) Yanming Zhou et al. WORLD JOURNAL OF SURGERY
- Implementation of an enhanced recovery programme following pancreaticoduodenectomy
- (2012) Nichola Robertson et al. HPB
- Paclitaxel resistance is associated with switch from apoptotic to autophagic cell death in MCF-7 breast cancer cells
- (2012) G M A Ajabnoor et al. Cell Death & Disease
- Arterial Resection During Pancreatectomy for Pancreatic Cancer
- (2011) Nathan Mollberg et al. ANNALS OF SURGERY
- Tumor Engraftment in Nude Mice and Enrichment in Stroma- Related Gene Pathways Predict Poor Survival and Resistance to Gemcitabine in Patients with Pancreatic Cancer
- (2011) I. Garrido-Laguna et al. CLINICAL CANCER RESEARCH
- Oxaliplatin: a review in the era of molecularly targeted therapy
- (2011) T. Alcindor et al. Current Oncology
- Axitinib plus gemcitabine versus placebo plus gemcitabine in patients with advanced pancreatic adenocarcinoma: a double-blind randomised phase 3 study
- (2011) Hedy L Kindler et al. LANCET ONCOLOGY
- II-Tubulin and III-Tubulin Mediate Sensitivity to Peloruside A and Laulimalide, but not Paclitaxel or Vinblastine, in Human Ovarian Carcinoma Cells
- (2011) A. Kanakkanthara et al. MOLECULAR CANCER THERAPEUTICS
- FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
- (2011) Thierry Conroy et al. NEW ENGLAND JOURNAL OF MEDICINE
- Expression and promoter methylation analysis of ATP-binding cassette genes in pancreatic cancer
- (2011) Yi Miao ONCOLOGY REPORTS
- Cisplatin as an Anti-Tumor Drug: Cellular Mechanisms of Activity, Drug Resistance and Induced Side Effects
- (2011) Ana-Maria Florea et al. Cancers
- Effect of Hospital Volume, Surgeon Experience, and Surgeon Volume on Patient Outcomes After Pancreaticoduodenectomy
- (2010) C. Max Schmidt ARCHIVES OF SURGERY
- Differential transport of platinum compounds by the human organic cation transporter hOCT2 (hSLC22A2)
- (2010) H Burger et al. BRITISH JOURNAL OF PHARMACOLOGY
- Three-Dimensional Collagen I Promotes Gemcitabine Resistance in Pancreatic Cancer through MT1-MMP-Mediated Expression of HMGA2
- (2010) S. Dangi-Garimella et al. CANCER RESEARCH
- Displacement of Bim by Bmf and Puma rather than increase in Bim level mediates paclitaxel-induced apoptosis in breast cancer cells
- (2010) O Kutuk et al. CELL DEATH AND DIFFERENTIATION
- Gemcitabine Plus Bevacizumab Compared With Gemcitabine Plus Placebo in Patients With Advanced Pancreatic Cancer: Phase III Trial of the Cancer and Leukemia Group B (CALGB 80303)
- (2010) Hedy Lee Kindler et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase III Study Comparing Gemcitabine Plus Cetuximab Versus Gemcitabine in Patients With Advanced Pancreatic Adenocarcinoma: Southwest Oncology Group–Directed Intergroup Trial S0205
- (2010) Philip A. Philip et al. JOURNAL OF CLINICAL ONCOLOGY
- Preoperative Biliary Drainage for Cancer of the Head of the Pancreas
- (2010) Niels A. van der Gaag et al. NEW ENGLAND JOURNAL OF MEDICINE
- Masitinib Combined with Standard Gemcitabine Chemotherapy: In Vitro and In Vivo Studies in Human Pancreatic Tumour Cell Lines and Ectopic Mouse Model
- (2010) Martine Humbert et al. PLoS One
- Total Pancreatectomy for Pancreatic Adenocarcinoma
- (2009) Sushanth Reddy et al. ANNALS OF SURGERY
- Long-Term Survival After Multidisciplinary Management of Resected Pancreatic Adenocarcinoma
- (2009) Matthew H. G. Katz et al. ANNALS OF SURGICAL ONCOLOGY
- Increased levels and defective glycosylation of MRPs in ovarian carcinoma cells resistant to oxaliplatin
- (2009) Giovanni Luca Beretta et al. BIOCHEMICAL PHARMACOLOGY
- Surgical gastrojejunostomy or endoscopic stent placement for the palliation of malignant gastric outlet obstruction (SUSTENT study): a multicenter randomized trial
- (2009) Suzanne M. Jeurnink et al. GASTROINTESTINAL ENDOSCOPY
- Targeting AKT with the proapoptotic peptide, TAT-CTMP: A novel strategy for the treatment of human pancreatic adenocarcinoma
- (2009) Peter O. Simon et al. INTERNATIONAL JOURNAL OF CANCER
- Variations in Referral Patterns to High-Volume Centers for Pancreatic Cancer
- (2009) David C. Chang et al. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS
- A proteomic approach links decreased pyruvate kinase M2 expression to oxaliplatin resistance in patients with colorectal cancer and in human cell lines
- (2009) E. Martinez-Balibrea et al. MOLECULAR CANCER THERAPEUTICS
- MicroRNA-21 modulates biological functions of pancreatic cancer cells including their proliferation, invasion, and chemoresistance
- (2009) T. Moriyama et al. MOLECULAR CANCER THERAPEUTICS
- Inhibition of Hedgehog Signaling Enhances Delivery of Chemotherapy in a Mouse Model of Pancreatic Cancer
- (2009) K. P. Olive et al. SCIENCE
- Nuclear Factor- B p65/relA Silencing Induces Apoptosis and Increases Gemcitabine Effectiveness in a Subset of Pancreatic Cancer Cells
- (2008) X. Pan et al. CLINICAL CANCER RESEARCH
- Randomized Crossover Pharmacokinetic Study of Solvent-Based Paclitaxel and nab-Paclitaxel
- (2008) E. R. Gardner et al. CLINICAL CANCER RESEARCH
- Significance of Organic Cation Transporter 3 (SLC22A3) Expression for the Cytotoxic Effect of Oxaliplatin in Colorectal Cancer
- (2008) S. Yokoo et al. DRUG METABOLISM AND DISPOSITION
- Peri-operative mortality and long-term survival after total pancreatectomy for pancreatic adenocarcinoma: A population-based perspective
- (2008) Hari Nathan et al. JOURNAL OF SURGICAL ONCOLOGY
- 5-Fluorouracil: Mechanisms of Resistance and Reversal Strategies
- (2008) Ning Zhang et al. MOLECULES
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search